GENE WRITING

Serial Number 90071417
602

Registration Progress

Application Filed
Jul 24, 2020
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: GENE WRITING
Previous Owner: Tessera Therapeutics, Inc.
Classes: 042

Trademark Image

GENE WRITING

Basic Information

Serial Number
90071417
Filing Date
July 24, 2020
Abandonment Date
March 13, 2023
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Mar 27, 2023
Classes
042

Rights Holder

Tessera Therapeutics, Inc.

03
Address
200 Sidney Street
Cambridge, MA 02139

Ownership History

Tessera Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Legal Representation

Attorney
Christina M. Licursi

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

32 events
Date Code Type Description Documents
Mar 28, 2023 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Mar 27, 2023 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Mar 27, 2023 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 2, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2022 GNS1 O NOTIFICATION OF SUBSEQUENT FINAL EMAILED Loading...
Sep 12, 2022 GNSF O SUBSEQUENT FINAL EMAILED Loading...
Sep 12, 2022 CFRC R SUBSEQUENT FINAL REFUSAL WRITTEN Loading...
Aug 12, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 11, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 11, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 11, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 11, 2022 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 11, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 7, 2021 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Dec 6, 2021 IUAA P USE AMENDMENT ACCEPTED Loading...
Dec 4, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 3, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Dec 3, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
Dec 4, 2021 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Dec 4, 2021 IUAF S USE AMENDMENT FILED Loading...
Dec 3, 2021 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Jun 3, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Jun 3, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
Jun 3, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
May 12, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 12, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 12, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 12, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 10, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...

Detailed Classifications

Class 042
Research and development in the field of technology and engineering for the modification of DNA; development of new technology for others for enabling the engineering and modification of DNA, namely, developing molecular and cellular biology reagents, techniques, and assays for the modification of cells and DNA
First Use Anywhere: Dec 3, 2021
First Use in Commerce: Dec 3, 2021

Classification

International Classes
042